Penicillin Allergy Delabeling

Image
Improve access to safer, less toxic antibiotics by correct identification of those who are allergic

According to United States Centers for Disease Control, approximately 10% of all US patients report having an allergic reaction to a penicillin class antibiotic in their past. When evaluated, however, fewer than 1% of the population are found to be truly allergic.

This page contains resources to support health care professionals with their penicillin allergy delabeling efforts.

Webinar Mini-Series for Health Care Professionals

Session 1: Introduction to Penicillin Allergy Delabeling

  • Presented by Jessica Zering, PharmD - Antimicrobial Stewardship Pharmacist at WA DOH
  • Dr. Zering gives a brief overview of this topic and discusses why it is important.
  • Slides of presentation (PDF)

Session 2: Penicillin Allergy Delabeling at Seattle Children's Hospital

  • Presented by Victoria Konold, MD – Assistant Professor, Pediatric Infectious Diseases at Seattle Children's Hospital/University of Washington
  • Dr. Konold describes her team’s approach to penicillin allergy delabeling in the hospital setting.
  • Slides of presentation (PDF)

Session 3: Penicillin Allergy Labels – Pathways Forward in Patient Care

  • Presented by Paul Pottinger, MD, and Rupali Jain, PharmD – University of Washington
  • Dr. Pottinger and Dr. Jain give a brief overview of penicillin allergy labels, describe the University of Washington's current initiatives (decision tools and pre-op), and share a vision for primary care.
  • Slides of presentation (PDF)

Session 4: Antibiotic Allergy Delabeling Journal Club

  • Presented by Erica Stohs, MD, MPH – Lead Antimicrobial Stewardship Policy Advisor at WA DOH
  • Dr. Stohs reviews the PALACE study and a beta-lactam allergy delabeling intervention performed in a community hospital.
  • Slides of presentation (PDF)

General Educational Resources for Patients

These educational resources are intended to be given to eligible patients by health care providers.

Specialized Educational Resources for Patients

These educational resources are intended to be given to eligible patients by health care providers participating in an established penicillin allergy desensitization program.

Facts About Penicillin Allergy Desensitization (PDF) | Spanish (PDF)

  • Desensitization is intended for patients who have a moderate to high risk of severe allergy needing urgent treatment with penicillins (e.g., treatment of syphilis with a confirmed penicillin allergy).
  • Desensitization and de-labeling are separate processes. See General Education Resources for patient education for penicillin allergy de-labeling.

Implementation Guidance

Clinical Guidance

Assessment Tools

Education for Healthcare Providers

Questions and Feedback

Email: ams@doh.wa.gov